Jiwoon Chang, MD
Peer Reviewed
This past week we witnessed another senseless mass shooting in San Bernardino, California that killed 14 people. The FBI is investigating this act of violence as a terror attack …
Jiwoon Chang, MD
Peer Reviewed
This past week we witnessed another senseless mass shooting in San Bernardino, California that killed 14 people. The FBI is investigating this act of violence as a terror attack …
By Noam Broder, MD
This week in Primecuts we take a moment to honor the victims of the recent terror attacks in Paris and the emergency response teams who cared for the wounded. According to the Wall Street Journal, Paris’s hospital authority triggered its …
By Amy Shen Tang, MD
Friday, November 13th unfortunately proved to be more than an unlucky day for Parisians. What initially sounded like firecrackers outside a soccer match at the Stade de France, with President Francois Hollande in attendance, was …
By: Loren Franco, MD
Russia has suspended all flights to Egypt amidst mounting reports and evidence that a terrorist bomb took down the Metrojet flight to St. Petersburg. Last week on October 31st, a Metrojet plane carrying 224 individuals exploded soon after taking …
By Stephanie Wu, MD
Peer Reviewed
This past weekend, we cheered for the 50,000 people who ran the NYC marathon. Jonathan Mendes, at 94 years old, tackled this marathon for his 14th time [1]. In the midst of this momentous and triumphant occasion, we witnessed …
By: Rory Abrams, MD
This past week the Mets became the 2015 National League Champions and are headed to the World Series. Larry David stole our hearts and minds after his impersonation of Bernie Sanders on SNL. Joe Biden officially …
By Abinav Baweja, MD
This past week we witnessed the first democratic national debate, where Hillary Rodham Clinton quieted doubters with her strong showing and minimized talk regarding her e-mail account. Meanwhile, ex-NBA player …
Olivia Begasse de Dhaem, MD
Peer Reviewed
Last month, Turing Pharmaceutical bought the rights to pyrimethamine, also known as Daraprim, and subsequently raised its price significantly (from $13.5 to $750 per tablet). Unlike Rodelis Therapeutics who …